These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3150272)

  • 1. Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models.
    Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R; Göres E
    Biomed Biochim Acta; 1988; 47(10-11):S289-92. PubMed ID: 3150272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lipoxygenase (LOX) or of cyclooxygenase (COX) improves survival of rats in endotoxin shock.
    Schaper U; Lueddeckens G; Förster W; Scheuch DW
    Biomed Biochim Acta; 1988; 47(10-11):S282-5. PubMed ID: 3150270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-induced death in NMRI mice--a suitable shock model for testing new PAF receptor antagonists. Correlation with eicosanoid related substances.
    Becker K; Lueddeckens G; Grupe R; Förster W
    Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):265-71. PubMed ID: 8385779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
    Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R
    Prog Clin Biol Res; 1989; 301():229-33. PubMed ID: 2798447
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of cyclo-oxygenase and lipoxygenase inhibitors on anaphylactic vasodepression ex vivo in mice and rats].
    Bekemeier H; Hänsel F; Sänze JU
    Pharmazie; 1988 Nov; 43(11):784-5. PubMed ID: 3150059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat.
    Gaytán M; Bellido C; Morales C; Sánchez-Criado JE; Gaytán F
    Reproduction; 2006 Oct; 132(4):571-7. PubMed ID: 17008468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
    Terashita Z; Imura Y; Nishikawa K; Sumida S
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors as well as of oxygen free radical scavengers (OFRS) in the inflammation-induced vasodepression.
    Kuhn C; Bekemeier H; Hirschelmann R; Giessler AJ
    Biomed Biochim Acta; 1988; 47(10-11):S320-3. PubMed ID: 3150275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of cyclooxygenase and lipoxygenase inhibitors: the prerequisites for more effective anti-inflammatory combinations].
    Vlaskovska M
    Eksp Med Morfol; 1990; 29(1):44-53. PubMed ID: 2118852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
    Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
    Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of aspirin in endotoxic shock.
    Halushka PV; Wise WC; Cook JA
    J Pharmacol Exp Ther; 1981 Aug; 218(2):464-9. PubMed ID: 6894770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors.
    Kälvegren H; Andersson J; Grenegård M; Bengtsson T
    Eur J Pharmacol; 2007 Jul; 566(1-3):20-7. PubMed ID: 17459368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The arrhythmogenic effect of platelet activating factor (PAF) is inhibited by PAF antagonist and by substances influencing eicosanoids.
    Mest HJ; Riedel A; Braquet P; Meyer E
    Biomed Biochim Acta; 1988; 47(10-11):S219-23. PubMed ID: 3248107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats.
    Rodrigue ME; Lacasse-M S; Larivière R; Lebel M
    Can J Physiol Pharmacol; 2005 Jun; 83(6):467-75. PubMed ID: 16049546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways.
    Lauri D; Cerletti C; de Gaetano G
    J Lab Clin Med; 1985 Jun; 105(6):653-8. PubMed ID: 3923145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.